Sirio Pharma

Sirio Pharma

Advance nutrition science and technology to deliver value to health

Sirio Pharma Co., Ltd. (SIRIO), founded in 1993, was listed on the Shenzhen Stock Exchange in 2019 (stock code: 300791.SZ). After over thirty years of rapid growth, SIRIO has emerged as a globally recognized contract R&D and manufacturing leader in the nutritional health food industry, offering a complete suite of end-to-end solutions, from research and product development to manufacturing, packaging, logistics, and marketing support.
SIRIO is committed to serving clients and consumers worldwide, operating seven advanced and automated production bases and five R&D centers across the globe. Through strategic partnerships with leading domestic and international enterprises, the company has positioned itself as one of the most influential players in the industry.

Corporate Culture

Vision
A trailblazer in nutritional health innovation
The trusted partner for our clients
Mission
Advance nutrition science and technology to deliver value to health
Values
Service, Innovative, Responsible, Initiative, Open
NO.1
The first publicly listed CDMO in the nutraceutical sector
6000+
Mature formulations
300+
Health food registration (blue-hat certified products)
80+
Invention patents

Company Milestones

1993

SIRIO was founded

Began pharmaceutical manufacturing

1999

Began manufacturing nutritional health foods

2002

Launched export operations

2003

Achieved GMP certification for pharmaceuticals

Expanded to North American and European markets

2007

Opened a second facility at the Shantou production site, expanding to multi-dosage manufacturing

2010

Opened US Branch

2013

Launched the plant-based softgel production line

2015

Established Ma'anshan Health Industrial Park

2016

Acquired Ayanda GmbH (Germany), now is Sirio Pharma Germany

Obtained UL certification (USA)

2019

Listed on the A-share market (300791.SZ)

2021

Launched the digital transformation initiative for the health and wellness industry

2022

Established the Shanghai R&D Center

Launched the Ma’anshan smart warehouse

2023

Acquired Best Formulations LLC (USA)

Started operations at Zhuhai Bonded Factory

2024

Launched a new automated packaging line in Sirio Pharma Germany

NF-Ubidecarenone Chewable Gels included in the United States Pharmacopeia

Launched the E-Cube Bioinspired Efficacy Technology Platform

1993
1999
2002
2003
2007
2010
2013
2015
2016
2019
2021
2022
2023
2024

Advancing Global Health

Partnering worldwide to explore new frontiers in the health and nutrition industry

Contact us
X

*必须项
×